A Study of KM257 in Patients With Advanced HER2-positive or Expressing Solid Tumors.

Clinical trial NCT05320874 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05320874
Sponsor: Xuanzhu Biopharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-04-01
Primary completion: 2024-06-01
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.